South San Francisco-based Frontier Medicines, a biopharmaceutical company, has raised $67 million in funding. Deerfield Management, Droia Oncology Ventures and MPM Capital led the round.
Source: Press Release
South San Francisco-based Frontier Medicines, a biopharmaceutical company, has raised $67 million in funding. Deerfield Management, Droia Oncology Ventures and MPM Capital led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination